Does lymph node assessment change the prognostic significance of substantial LVSI and p53 status in endometrial endometrioid carcinoma?

Hui, Caressa; Mendoza, Maria G; von Eyben, Rie; Dorigo, Oliver; Litkouhi, Babak; Renz, Malte; Karam, Amer; Hammer, Phoebe M; Howitt, Brooke E; Kidd, Elizabeth

Hui, Caressa; Mendoza, Maria G; von Eyben, Rie; Dorigo, Oliver; Litkouhi, Babak; Renz, Malte; Karam, Amer; Hammer, Phoebe M; Howitt, Brooke E; Kidd, Elizabeth.

Afiliação

Hui C; Department of Radiation Oncology, Stanford University, USA.
Mendoza MG; Department of Radiation Oncology, Stanford University, USA.
von Eyben R; Department of Radiation Oncology, Stanford University, USA.
Dorigo O; Division Gynecologic Oncology, Stanford Department of Obstetrics and Gynecology, Stanford Women's Cancer Center and Stanford Cancer Institute, USA.
Litkouhi B; Division Gynecologic Oncology, Stanford Department of Obstetrics and Gynecology, Stanford Women's Cancer Center and Stanford Cancer Institute, USA.
Renz M; Division Gynecologic Oncology, Stanford Department of Obstetrics and Gynecology, Stanford Women's Cancer Center and Stanford Cancer Institute, USA.
Karam A; Division Gynecologic Oncology, Stanford Department of Obstetrics and Gynecology, Stanford Women's Cancer Center and Stanford Cancer Institute, USA.
Hammer PM; Department of Pathology, Stanford University, USA.
Howitt BE; Department of Pathology, Stanford University, USA.
Kidd E; Department of Radiation Oncology, Stanford University, USA. Electronic address: ekidd@stanford.edu.